Condition

Bladder Urothelial Carcinoma In Situ (2)

Stage 0a Bladder Cancer AJCC v8 (2)

Stage 0is Bladder Cancer AJCC v8 (2)

Stage I Bladder Cancer AJCC v8 (2)

Infiltrating Bladder Mixed Carcinoma (1)

Recurrent Bladder Urothelial Carcinoma (1)

Superficial Bladder Urothelial Carcinoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Fred Hutchinson Cancer Center (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

acupuncture therapy (1)

bcg solution (1)

best practice (1)

gemcitabine hydrochloride (1)

pembrolizumab (1)

quality-of-life assessment (1)

questionnaire administration (1)

Study Documents

Intervention Type

biological (2)

device (1)

drug (1)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

bladder urothelial carcinoma in situ

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bladder Urothelial Carcinoma In Situ, Infiltrating Bladder Mixed Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Guam,

Recruiting

Bladder Urothelial Carcinoma In Situ
+4 more

Gemcitabine Hydrochloride
Pembrolizumab

Birmingham, Alabama
+379 more

Aug 23, 2022

Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle

Recruiting

Bladder Urothelial Carcinoma In Situ
+5 more

Acupuncture Therapy
+4 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

May 27, 2022